ArticleDiabetes, metabolic syndrome and obesity : targets and therapy2024

Early Conversion of Intensive Insulin Therapy to IDegLira Demonstrates Higher Efficacy and Safety in Reducing Fasting Blood Glucose and HbA1c in T2DM Patients.

Caiyun Guo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.